Alvaro Quintanal-Villalonga Selected Research

Alvaro Quintanal-Villalonga Research Topics

11	Neoplasms (Cancer) 10/2023 - 12/2017
5	Lung Neoplasms (Lung Cancer) 10/2023 - 12/2017
3	Adenocarcinoma 01/2023 - 01/2019
3	Adenocarcinoma of Lung 01/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2023
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 12/2021
1	Small Cell Carcinoma 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2019

4	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2017
2	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2023
2	osimertinibIBA 01/2023 - 10/2021
2	selinexorIBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2017
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2017
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Small Cytoplasmic RNAIBA 10/2023
1	B7-H1 AntigenIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Aromatase InhibitorsIBA 01/2023
1	Exportin 1 ProteinIBA 01/2023
1	enzalutamideIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 10/2019
1	Co-Repressor ProteinsIBA 10/2019
1	APOBEC-1 DeaminaseIBA 10/2019
1	Cytidine DeaminaseIBA 10/2019
1	LigandsIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2019
1	neurabinIBA 12/2017
1	Adenosine Triphosphate (ATP)IBA 12/2017